Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-002547-83-DE
EUCTR2006-002547-83-DE
Active, not recruiting
Not Applicable

GnRH-Agonisten-Therapie bei Frauen mit Endometriose der Stadien III-IV nach rASRM-Kriterien vor reproduktionsmedizinischen Techniken (IVF / ICSI) (GARTE-Studie) - GARTE

Dr. Peter Sydow0 sitesNovember 20, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsWomen with endometriosis who have been diagnosed with Stages III -IV according to rASRM criteria
DrugsEnantone-Gyn Monats-Depot

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Women with endometriosis who have been diagnosed with Stages III -IV according to rASRM criteria
Sponsor
Dr. Peter Sydow
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2006
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Dr. Peter Sydow

Eligibility Criteria

Inclusion Criteria

  • •women of age 18\-40 with diagnosis of endometriosis stages III\-IV according to rASRM criteria who had surgery during the last 3 month before beeing recruites to the study
  • •FSH\<12 IU/ml
  • •signed informed consent
  • •negative pregnancy test
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •pregnancy and lactation
  • •all contraindications against tested medication
  • •all possible interaction (e.g. allergies) with tested medication
  • •participation in other clinical trial parallel or 8 weeks prior to this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Treating Endometriosis: Pill of Dienogest alone vs. Pill of Dienogest with Hormonal Intrauterine Device - a randomized clinical trial
RBR-68j3f26niversidade Estadual de Campinas
Recruiting
Not Applicable
Prediction of Therapy Responde in Endometriosis patientsN80Endometriosis
DRKS00021236Klinik für Gynäkologie und GeburtsmedizinRWTH Uniklinik Aachen200
Completed
Not Applicable
Pain control in patients with endometriosis through relaxation methods and activity exercises supported by virtual reality technologyN80Endometriosis
DRKS00030189Department für Frauengesundheit23
Recruiting
Phase 2
A GnRH Agonist IN pre-menopausal women STudy to treat severe Polycystic Liver DiseaseCystic liversPolycystic liver disease100198061001965410038430
NL-OMON50796niversitair Medisch Centrum Groningen18
Completed
Phase 3
The AGAINST-PLD Study; An investigator-driven, randomized, open label clinical trial assessing efficacy of leuprorelin to halt disease progression in PLD
2023-506637-30-00Universitair Medisch Centrum Groningen36